Beyond the well-established BRCA1/2 and Lynch syndrome genes, large panels can identify pathogenic variants in other moderate-to-high penetrance genes, such as PALB2 and CHEK2, which are implicated in both breast and colorectal cancer risks (33). The gene discussed is CHEK2; the disease is Lynch syndrome.